Frequency of Hypoglycemia and Its Significance in Chronic Kidney Disease
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
BACKGROUND AND OBJECTIVES: This study set out to determine the incidence of hypoglycemia in patients with chronic kidney disease (CKD), with and without diabetes, and the association of hypoglycemia with mortality. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: This was a retrospective cohort analysis of 243,222 patients who had 2,040,206 glucose measurements and were cared for at the Veterans Health Administration. CKD was defined as an estimated GFR of <60 ml/min per 1.73 m(2). Hypoglycemia was set at <70 mg/dl. Mortality was measured 1 day after glucose measurement. RESULTS: The incidence of hypoglycemia was higher in patients with CKD versus without CKD. Among patients with diabetes, the rate was 10.72 versus 5.33 per 100 patient-months and among patients without diabetes was 3.46 versus 2.23 per 100 patient-months, for CKD versus no CKD, respectively. The odds of 1-d mortality were increased at all levels of hypoglycemia but attenuated in CKD versus no CKD. Adjusted odds ratios for 1-d mortality that were associated with glucose values of <50, 50 to 59, and 60 to 69 mg/dl, respectively, versus glucose of >or=70 mg/dl were 6.09, 4.10, and 1.85 for inpatient records from patients with CKD; 9.95, 3.79, and 2.54 for inpatients records from patients without CKD; 6.84, 3.28, and 3.98 for outpatient records from patients with CKD; and 13.28, 7.36, and 4.34 for outpatient records from patients without CKD. CONCLUSIONS: CKD is a risk for hypoglycemia, with or without diabetes. The excessive mortality associated with hypoglycemia makes this complication a significant threat to patient safety in CKD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“CKD is a risk factor for non-diabetic hypoglycemia, as reflected in significantly higher hypoglycemia rates in patients with CKD compared to patients without CKD (3.46 vs. 2.23/100 patient-months, p < 0.0001) [29].”
From Non-Diabetic Hypoglycemia: Evaluation and Management in Adults (2025) · cites this paper as [29]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Effects of Intensive Glucose Lowering in Type 2 Diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802743 · Cited by 7,888
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes
(2008) · New England Journal of Medicine · doi:10.1056/nejmoa0802987 · Cited by 7,397
Glucose control and vascular complications in veterans with type 2 diabetes
Duckworth, W., Abraira, C., Moritz, T., Reda, D., Emanuele, N., Reaven, P. D., Zieve, F. J., Marks, J., Davis, S. N., Hayward, R., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0808431 · Cited by 4,762
Assessing Kidney Function — Measured and Estimated Glomerular Filtration Rate
Stevens, L. A., Coresh, J., Greene, T., & Levey, A. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra054415 · Cited by 2,952 · cited 2×
“Both the Action in Diabetes and Vascular Disease: Preterax and Diamicron Modified Release Controlled Evaluation (ADVANCE) and the Veterans Affairs Diabetes Trial (VADT) found that severe hypoglycemia was more common in an intensive glucose-lowering group than a control group, but the two treatment groups had similar m…”
BackgroundMethodInfluential(2000) · Journal of the American Society of Nephrology · Cited by 1,718
Gerstein, H. C., Miller, M., & Byington, R. P. (2010) · Cited by 981
Frequency of Severe Hypoglycemia Requiring Emergency Treatment in Type 1 and Type 2 Diabetes
Leese, G. P., Wang, J., Broomhall, J., Kelly, P., Marsden, A., Morrison, W., Frier, B. M., Morris, A. D., & For the DARTS/MEMO Collaboration (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1176 · Cited by 559 · cited 1×
“The selection of these cut points was derived from definitions of hypoglycemia used in previous studies (5, 17 ,18), but because none of them was used exclusively, we elected to incorporate all of them as measures of hypoglycemic severity.”
MethodMechanisms of abnormal cardiac repolarization during insulin-induced hypoglycemia
Robinson, R. T. C. E., Harris, N. D., Ireland, R. H., Lee, S., Newman, C., & Heller, S. R. (2003) · Diabetes · doi:10.2337/diabetes.52.6.1469 · Cited by 264 · cited 2×
“In addition, acute hypoglycemia can result in a surge in adrenergic activity, which can result in coronary ischemia, serious cardiac arrhythmias, and sudden death (7).”
BackgroundValidation of ICD-9-CM coding algorithm for improved identification of hypoglycemia visits
Ginde, A. A., Blanc, P. G., Lieberman, R. M., & Camargo, C. A. (2008) · BMC Endocrine Disorders · doi:10.1186/1472-6823-8-4 · Cited by 234
Snyder, R. W., & Berns, J. S. (2004) · Seminars in Dialysis · doi:10.1111/j.0894-0959.2004.17346.x · Cited by 215
Research works printed but not linked: 1
- [6]Berlin KS, Sass DA, Davies WH, Reupert S, Hains AA: Brief report: Parent perceptions of hypoglycemic symptoms in youth with diabetes. J Pediatr Psychol 30: 207–212, 2005 [DOI] [PubMed] [Google Scholar]
Cited by
Items 301–400 of 428
Insulin therapy in diabetic kidney disease
Liu, Y., Zhao, C., Xiong, X., Yang, M., & Sun, L. (2021) · Diabetic Nephropathy · doi:10.2478/dine-2022-0006 · Cited by 2
Simultaneous pancreas and kidney transplantation: A qualitative study of partners’ experiences
Hann, K. E. J., Cinnirella, M., Bradley, C., & Gibbons, A. (2024) · PLoS ONE · doi:10.1371/journal.pone.0313907 · Cited by 2
Association of fructose-1,6-diphosphatase 1 with the progression of diabetic kidney disease
Fu, Z., Chen, Z., Bian, S., Li, L., Geng, S., Dong, J., Liu, S., Wu, L., Zhu, J., Guo, H., et al. (2025) · Nutrition & Metabolism · doi:10.1186/s12986-025-01038-4 · Cited by 2
“While CKD typically demonstrates decreased renal FBP1 expression [27, 31, 32], our study reveals a paradoxical upregulation of FBP1 in early-stage DKD, mirroring the 40–200% increase in hepatic gluconeogenesis seen in diabetes due to insulin resistance [33].”
InfluentialLiu, W.-C., Chiu, L.-S., & Lim, P. (2022) · 童綜合醫學雜誌 · doi:10.4103/etmj.tmj-110022 · Cited by 2
Use of Second-Generation Basal Insulin Gla-300 in Special Populations: A Narrative Mini-Review
Ghosh, S. K., Kalra, S., Bantwal, G., & Sahay, R. K. (2023) · Current Diabetes Reviews · doi:10.2174/1573399819666230109113205 · Cited by 2
“Renal impairment is an independent risk factor for hypo-glycemia which increases the risk of hypoglycemia in people with type 2 diabetes mellitus (T2DM) [11, 12].”
BackgroundKim, M. J., Kim, H. S., Cho, Y. K., Jung, C. H., & Lee, W. J. (2024) · Clinical Therapeutics · doi:10.1016/j.clinthera.2024.06.024 · Cited by 2
Tian, K., Ang, L. C., Choudhary, P., Choo, J. C. J., Bee, Y. M., Goh, S., & Teh, M. M. (2024) · Diabetic Medicine · doi:10.1111/dme.15438 · Cited by 2
“This adds to the evidence that chronic kidney disease is an independent predictor of hypoglycaemia events, 15 and we must pay particular attention to this group of patients.”
Morris, D. (2014) · Independent Nurse · doi:10.12968/indn.2014.15.20 · Cited by 2
Waqar, H., & Danial, K. (2012) · InTech eBooks · doi:10.5772/39228 · Cited by 3
Canagliflozin (Invokana®): a First-in-Class Anti-diabetic Drug
Sen, S. (2013) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v3i3.490 · Cited by 4
Severe Hypoglycemia in Patients with Diabetes
Yun, J. S., & Ko, S. (2012) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2012.36.4.273 · Cited by 2
“According to previous studies, severe hypoglycemia has several predictive risk factors such as age, duration of diabetes, duration of insulin treatment, hypoglycemic events occurring in the preceding months, peripheral neuropathy, and, in particular, impaired kidney function [6,9,10].”
MethodAnti-Diabetes Therapy: Safety Considerations for Patients With Impaired Kidney Function
McGill, J. B. (2014) · Postgraduate Medicine · doi:10.3810/pgm.2014.05.2765 · Cited by 4
Rombopoulos, G., Panitti, E., Varounis, C., Katsinas, C., Stefanidis, I., & Goumenos, D. S. (2016) · Current Medical Research and Opinion · doi:10.1185/03007995.2016.1151777 · Cited by 2
Insulinoma and Chronic Kidney Disease: An Uncommon Conundrum Not to Be Overlooked
Foppiani, L., Panarello, S., Filauro, M., Scirocco, M. C., Cappato, S., Parodi, A. F., Sola, S., & Antonucci, G. (2017) · Clinical Medicine Insights Endocrinology and Diabetes · doi:10.1177/1179551417742620 · Cited by 2
Estrategia terapéutica en el paciente diabético (III). Insulinoterapia
Ocaña, P. G., Cobos-Palacios, L., Muriel, C. C., & Jansen‐Chaparro, S. (2020) · Medicine - Programa de Formación Médica Continuada Acreditado · doi:10.1016/j.med.2020.09.021 · Cited by 2
Afghahi, H., Nasic, S., Rydell, H., Svensson, J., & Peters, B. (2022) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2022.110033 · Cited by 2
Yasukawa, R., Hosojima, M., Kabasawa, H., Takeyama, A., Ugamura, D., Suzuki, Y., Saito, A., & Narita, I. (2022) · Renal Replacement Therapy · doi:10.1186/s41100-022-00432-5 · Cited by 3
“Hypoglycemia has been associated with increased risk of excess mortality in patients with chronic kidney disease [25].”
BackgroundKim, J. Y., Han, J. M., Yun, B., Yee, J., & Gwak, H. S. (2023) · HORMONES · doi:10.1007/s42000-023-00492-0 · Cited by 2
Hyperglycaemia in people with diabetes and chronic kidney disease
Brøsen, J. M. B., Bomholt, T., Borg, R., Persson, F., & Pedersen‐Bjergaard, U. (2024) · Ugeskrift for Læger · doi:10.61409/v01240051 · Cited by 2
Predicting hypoglycemia in ICU patients: a machine learning approach
Karasneh, R. A., Al-Azzam, S. I., Alzoubi, K. H., Ebbini, M. A. L., Alselwi, A., Rahhal, D., Kabbaha, S., Aldeyab, M. A., & Badr, A. F. (2024) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2024.2403039 · Cited by 1
Ling, Y., He, Y., Chang, T. H., Ruan, X., Ruan, H., Li, Z., Liu, J., Liu, Y., & Chen, J. (2025) · Acta Diabetologica · doi:10.1007/s00592-025-02493-4 · Cited by 1
“Several studies have demonstrated a high prevalence of hypoglycemia in patients with CKD, as well as an association between hypoglycemia and the risk of AKI [33, 34].”
Маркова, Т. Н., Yavorskaya, V. O., Ushakova, A. I., Андреевич, Б. В., Ibragimova, T. V., Кумахова, Л. А., Orlova, A. D., & Usatiuk, S. S. (2025) · Diabetes Mellitus · doi:10.14341/dm13194 · Cited by 1
George, K. M. (2025) · Journal of Medical Sciences and Health · doi:10.46347/jmsh.v11.i3.25.90 · Cited by 1
Aomura, D., Nimura, T., Yamaka, K., Yamada, Y., Harada, M., Nakajima, T., Kimura, T., Hashimoto, K., Kanno, H., Yanagita, M., et al. (2025) · The FASEB Journal · doi:10.1096/fj.202502975r · Cited by 1
Kakutani, Y., Morioka, T., Miyamoto, S., Natsuki, Y., Miki, Y., Ochi, A., & Emoto, M. (2026) · Diabetes Technology & Therapeutics · doi:10.1177/15209156261423902 · Cited by 2
“6 Furthermore, in patients with diabetes, hypoglycemia is more strongly associated with in-hospital mortality in those with CKD than in those without CKD. 7 Therefore, minimizing the risk of hypoglycemia is essential for effective glycemic control in hospitalized patients with coexisting diabetes and CKD. Continuous g…”
InfluentialKim, M., Katayama, A., Morimoto, E., Watanabe, M., Matsushita, Y., Takeda, M., Kitagawa, M., & Hida, K. (2026) · Internal Medicine · doi:10.2169/internalmedicine.6846-25 · Cited by 1
Lu, J. C., Meyer‐Olesen, C. L., Halim, B., Vogrin, S., Christensen, M. B., Apostolopoulos, J., Bomholt, T., MacIsaac, R. J., Lee, P., Trawley, S. L., et al. (2026) · Diabetologia · doi:10.1007/s00125-026-06732-3 · Cited by 1
“This phenomenon is multifactorial, driven by alterations in insulin and glucose metabolism that occur with advanced CKD, compounded by behavioural and cognitive factors [15].”
Williams, M. E., & Stanton, R. C. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-391934-2.00031-x · Cited by 1
Lomefloxacin-induced hypoglycemia in an elderly patient with chronic kidney disease:a case report
Jia, Z., Zheng, F.-P., & Li, H. (2015) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-014-0239-2 · Cited by 1
“Although the diagnosis of CKD could be an independent risk factor for hypoglycemia of any severity [8], the significantly elevated insulin secretion index (ISI=5.”
BackgroundSolini, A., & Castellino, P. (2019) · Endocrinology · doi:10.1007/978-3-319-27316-7_8-2 · Cited by 1
Management of Diabetes and/or Hyperglycemia in Hospitalized Patients with Renal Insufficiency
Matfin, G. (2018) · Wiley eBooks · doi:10.1002/9781119374800.ch37 · Cited by 1
Consensus on insulin treatment in type 2 diabetes
Borrás, J. A. G., Martín, J. E. S., Mata‐Cases, M., Peralta, F. G., Menéndez, S. A., García, D. F., Millán, C. O., Guisasola, F. Á., García, J. C. F., Loiola, P. E., et al. (2018) · Endocrinología Diabetes y Nutrición (English ed ) · doi:10.1016/j.endien.2018.01.003 · Cited by 3
Prevalence of Hypoglycemia Among Type 2 Diabetics Undergoing Hemodialysis in a University Hospital
Gungon, M. C. H., & Cunanan, E. C. (2020) · Journal of Medicine University of Santo Tomas · doi:10.35460/2546-1621.2018-0057 · Cited by 1
“33 per 100 patient-months for CKD versus no CKD, respectively.[3] A higher prevalence rate of 52.”
BackgroundInfluentialKamrul-Hasan, A. B. M., & Paul, A. (2020) · Journal of Diabetology · doi:10.4103/jod.jod_27_19 · Cited by 2
Preparation of the dialysis patient with type 1 diabetes mellitus for kidney transplantation
Martynov, S. A., Severina, A. S., Larina, I. M., Shamhalova, M., Арзуманов, С. В., Пинчук, А. В., & Shestakova, M. V. (2020) · Problems of Endocrinology · doi:10.14341/probl12686 · Cited by 2
Anephric Neonate and Evolution of our Study on Intestinal Dialysis
Chatterjee, U. S. (2021) · Journal of Indian Association of Pediatric Surgeons · doi:10.4103/jiaps.jiaps_3_20 · Cited by 1
“This is due to the absence of degradation of insulin in the kidney and the absence of compensatory gluconeogenesis from renal parenchyma.[15,16] Hence, there may be severe hypoglycemia from double attack.”
BackgroundHypoglycemia Caused by Endogenous Hyperinsulinism: A Case Study
Shah, K., KOTHARI, A. R., Bansode, A., & Aktar, T. (2021) · European Journal of Medical and Health Sciences · doi:10.24018/ejmed.2021.3.3.877 · Cited by 1
Chandran, K., Tai, K. P., Toh, M. P. H. S., Phng, F. W. L., Seah, E.-J. D., & Wu, C. X. (2019) · Journal of Endocrinology and Metabolism · doi:10.14740/jem563 · Cited by 1
Abdelhafiz, A. H. (2017) · Wiley eBooks · doi:10.1002/9781118954621.ch7 · Cited by 1
Galea, A., Farrugia, S., Calleja, N., & Coppini, D. (2022) · Practical Diabetes · doi:10.1002/pdi.2415 · Cited by 1
Practical guide in using insulin degludec/insulin aspart: A multidisciplinary approach in Malaysia
Chan, S. P., Mumtaz, M., Ratnasingam, J., Tan, A. T. B., Lim, S. C., Rosman, A., Chee, K. H., Lim, S. K., Yew, S. S., Yusof, B. N. M., et al. (2023) · Malaysian Family Physician · doi:10.51866/cpg.255 · Cited by 1
Pollock, C. A., Sánchez, J. J. G., Carrero, J. J., Kumar, S. R., Pecoits‐Filho, R., Lam, C. S. P., Chen, H., Kanda, E., Lainščak, M., & Wheeler, D. C. (2023) · Diabetic Medicine · doi:10.1111/dme.15200 · Cited by 1
“2,9 Optimising treatment regimens, including the timely use of glucose-lowering therapies that confer cardiorenal protection independent of glycaemic control, may improve outcomes in these individuals and minimise medication burden.”
BackgroundResultInfluentialRaherison, R. E., Raharinavalona, S. A., Ratsimbazafy, S. J. N., Randriamboavonjy, R., Randriamboavonjy, D., & Raveloson, N. (2015) · La revue médicale de Madagascar. · doi:10.62606/rmmao00164 · Cited by 1
Afandi, B. O., Odhaib, S. A., Habib, M., Aljohani, N., Ahmedani, M. Y., Elbarbary, N. S., Alfadhli, E. M., Kallash, M. A., & Hassanein, M. M. (2025) · Journal of Diabetes and Endocrine Practice · doi:10.1055/s-0045-1811949 · Cited by 1
“…hypoglycemia is lower in people with type 2 diabetes than in those with T1D, 20 it is no wonder our analysis shows a majority of 65% of patients in the DKD cohort reporting hypoglycemic episodes during Ramadan with more patients requiring hospital visits/admissions compared with the control ( ►…”
Diabetespatienten mit chronischer Niereninsuffizienz: Neue Aspekte in Diagnostik und Therapie
Pommer, W., & Oser, B. (2015) · Der Nephrologe · doi:10.1007/s11560-014-0974-x · Cited by 1
“Das Mortalitätsrisiko einer Hypoglykämie mit Glucosewerten zwischen 50 und 60 mg/dl (2,77 und 3,33 mmol) steigt im Vergleich zu einer Hypoglykämie mit einem Glucosewert >70 mg/dl (3,88 mmol/l) bei chronischer Niereninsuffzienz um das >6-Fache an [16].”
BackgroundCrook, D. E., Sehgal, V., Kukreja, M., & Sehgal, J. (2025) · doi:10.25259/peak_16_2025 · Cited by 1
Nierenersatztherapie bei Diabetes mellitus
Pommer, W. (2011) · Der Nephrologe · doi:10.1007/s11560-010-0512-4 · Cited by 1
Adding a DPP-4 inhibitor to metformin therapy may be safer than you think
Aravind, S. R. (2014) · Current Medical Research and Opinion · doi:10.1185/03007995.2014.893867 · Cited by 1
Betônico, C. D. C. R. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2017.tde-05042017-153224 · Cited by 1
Use of Available Glucose-Lowering Agents in Patients with Different Levels of Renal Impairment
Garvey, W. T. (2013) · Endocrine Practice · doi:10.4158/ep12362.or
Davidson, J. A. (2013) · Endocrine Practice · doi:10.4158/ep12360.or
Le diabète de type 2 au stade de l’insuline : Quelle place pour les inhibiteurs de la DPP-4 ?
Halimi, S., Charbonnel, B. H., Monguillon, P., & Dejager, S. (2015) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(15)30011-0 · Cited by 1
DPP-4 inhibitors and hypoglycemia in the patients with type 2 diabetes mellitus
Халимов, Ю. Ш. (2013) · Problems of Endocrinology · doi:10.14341/probl201359572-80
Yeo, J. H., Kim, J. E., Park, E. S., Park, J. H., Kim, D. S., Choi, W. H., Ahn, Y. H., Kim, H. J., Hong, S., & Lee, C. B. (2015) · Journal of the Korean Geriatrics Society · doi:10.4235/jkgs.2015.19.1.34
A case of recurrent hypoglycemia in pregnancy
Padmanabhan, V. (2015) · International Journal of Medicine and Public Health · doi:10.4103/2230-8598.165987
“In CKD, there is increased insulin sensitivity because of decreased clearance of insulin.[1,2] In addition, there is decreased gluconeogenesis in kidneys due to CKD.”
BackgroundWang, J. Y., Leiter, L. A., Langer, A., Tan, M., Goldin, L., Teoh, H., CHENG, A. Y. Y., Connelly, K. A., Goodman, S. G., & Yan, A. T.-K. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.07.070
Corticotrophin deficiency in end-stage renal failure led to recurrent hypoglycemia: A case report
Wagner, B., & Peter, H. (2015) · Medical Case Studies · doi:10.5897/mcs2015.0109
“The mortality is increased (Moen et al., 2009).”
Nutritional considerations in haemodialysis patients with diabetes
El‐Sherbini, N. (2016) · Journal of Kidney Care · doi:10.12968/jokc.2016.1.4.178
Diabetesassoziierte Nierenerkrankung
Stacheder, C., & Böger, C. A. (2017) · Der Diabetologe · doi:10.1007/s11428-017-0243-5
“Möglicherweise liegt der beobachteten erhöhten Mortalität ein erhöhtes Hypoglykämierisiko zugrunde [22].”
BackgroundKattan, W. (2017) · STARS (University of Central Florida)
75歳以上の高齢2型糖尿病患者におけるリナグリプチンの効果と肝腎機能,脂質代謝への影響―75歳未満患者との比較及び腎機能低下例での検討―
木田真美, 吉越仁美, 秀知, 小., さやか, 内., 修一, 佐., & 勝, 小. (2017) · 糖尿病 · doi:10.11213/tonyobyo.60.540
Diabetestherapie bei Niereninsuffizienz: Besonderheiten und Limitationen
Dischinger, U., Faßnacht, M., & Koschker, A. (2018) · Der Diabetologe · doi:10.1007/s11428-018-0311-5
Update on renal disease in diabetic patients in primary care
Morris, D. (2018) · Independent Nurse · doi:10.12968/indn.2018.9.32
It's never too late to look for alternatives to Insulin
Filippi, A. (2018) · AboutOpen · doi:10.19156/abtpn.2018.0048
Renal insufficiency and linagliptin therapy: a case report
Corsi, A., & Trevisan, R. (2018) · AboutOpen · doi:10.19156/abtpn.2018.0062
HIPOGLUCEMIAS EN PACIENTES CON ENFERMEDAD RENAL CRÓNICA
Medek, G. (2018) · Revista de la Sociedad Argentina de Diabetes · doi:10.47196/diab.v51i3.108 · Cited by 2
Glycemic Metrics and Targets in Kidney Disease
Neumiller, J. J., & Hirsch, I. B. (2019) · Springer eBooks · doi:10.1007/978-3-319-97765-2_4
Eine diabetische Nephropathie bestimmt die Diabetestherapie mit
Merker, L. (2019) · Info Diabetologie · doi:10.1007/s15034-019-1493-7
Therapie des Diabetes mellitus bei chronischer Nierenerkrankung
Bojunga, J., & Mondorf, A. W. (2019) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/a-0654-0783
“SH führen häufig zu einer Gewichtszunahme und haben ein relevantes Hypoglykämie-Risiko; Nebenwirkungen, deren Auftreten heute besonders unerwünscht sind.”
BackgroundInfluentialKramer, H., & Navaneethan, S. D. (2019) · Nephrology Self-Assessment Program · doi:10.1681/nsap.2019.18.4.12
Winocour, P. H., Moore-Haines, K., Sullivan, K. R., Currie, A., Solomon, A., & Hardy, D. (2020) · British Journal of Diabetes · doi:10.15277/bjd.2020.252
Putri, A. N., Novida, H., & Wardhani, P. (2021) · Care Jurnal Ilmiah Ilmu Kesehatan · doi:10.33366/jc.v9i1.1384 · Cited by 3
Tykhonova, T., Barabash, N., & Soldatenko, I. (2020) · The Journal of V N Karazin Kharkiv National University series Medicine · doi:10.26565/2313-6693-2020-39-15
Diabetes Management in the Elderly Patient with Kidney Disease
Molitch, M. E. (2015) · Cited by 2
Nephropathy and chronic renal insufficiency
Napoli, N. (2021) · Journal of Gerontology and Geriatrics · doi:10.36150/2499-6564-n455
Qureshi, R., Nasir, K., Dhrolia, M. F., & Ahmad, A. (2022) · Cureus · doi:10.7759/cureus.21291
“The benefits of metformin besides glucose control include reducing blood pressure and plasma lipids, reducing body weight, and increase in insulin sensitivity [3].”
BackgroundAbdelhafiz, A. H., & Sinclair, A. J. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch62 · Cited by 1
Alcohol-induced hemiplegia hypoglycemia in end stage renal disease patient: a case report
Juliarta, I. G., & Noverina, I. G. A. A. (2022) · International Journal of Advances in Medicine · doi:10.18203/2349-3933.ijam20220790
Williams, M. E., & Stanton, R. C. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-818540-7.00006-9
Solini, A., & Castellino, P. (2018) · Endocrinology · doi:10.1007/978-3-319-44433-8_8
Solini, A., & Castellino, P. (2020) · Endocrinology · doi:10.1007/978-3-030-36694-0_8 · Cited by 1
Solini, A., & Castellino, P. (2018) · Endocrinology · doi:10.1007/978-3-319-27316-7_8-1
Chronic Kidney Disease Is a Risk Enhancer for Cardiovascular Diseases
Padalia, K. J., & Hayek, S. S. (2022) · Contemporary cardiology · doi:10.1007/978-3-030-98824-1_14 · Cited by 1
The evidence behind early aggressive multi-drug treatment in type 2 diabetes
Cersósimo, E., Solis‐Herrera, C., & Triplitt, C. L. (2021) · Trends in Diabetes and Metabolism · doi:10.15761/tdm.1000121 · Cited by 1
Маркова, Т. Н., & Yavorskaya, V. O. (2022) · Diabetes Mellitus · doi:10.14341/dm12920
Pathogenesis, Pathophysiology, and Treatment of Diabetic Nephropathy
Bjornstad, P., Lytvyn, Y., de Zeeuw, D., & Cherney, D. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-47794-9.00026-3 · Cited by 1
Hypoglycemia in patients with COVID-19: risk factors and prevention of complications
Halushko, O. A., Процюк, О. В., & Pogorila, O. I. (2023) · Zaporozhye Medical Journal · doi:10.14739/2310-1210.2023.1.261797
Risk factors associated with the discordance in kidney function decline rate in identical twins
Hwang, J. A., Shin, J., Cho, E., Ahn, S. Y., Ko, G.-J., Kwon, Y., & Kim, J. E. (2023) · PLoS ONE · doi:10.1371/journal.pone.0284154
“Low blood glucose is known to be associated with increased mortality, CVD and ESRD in diabetes patients as well as the increased risk for the development of new-onset diabetes [30].”
BackgroundHypoglycemia in Patients with Type-2 Diabetes Mellitus Nephropathy
Rahman, F. U., Rahman, S., Haider, I., Munib, N., & Khan, W. M. (2023) · Journal of Aziz Fatimah Medical & Dental College · doi:10.55279/jafmdc.v5i1.227
Xayavong, B., Jirakajohnkool, S., Pannucharoenwong, N., Janchompu, W., Niammuad, D., & Pawa, K. K. (2023) · Research Square · doi:10.21203/rs.3.rs-3083579/v1
WITHDRAWN: Fasting blood glucose level and all-cause mortality in peritoneal dialysis patientsPreprint
(2023) · Research Square · doi:10.21203/rs.3.rs-2831443/v2
Diagnosis and management of diabetic kidney disease–Part 1
Morris, D. (2023) · Independent Nurse · doi:10.12968/indn.2023.12.14
¿Qué nos han demostrado los arGLP-1 en el abordaje integral temprano?
García, M. C. G., & Lachica, L. Á. (2023) · Diabetes práctica · doi:10.52102/diabet/pract.manejointegral.art3
Awasthi, R., Pande, A. K., Chandra, K. P., Agarwal, V., Gupta, M., Tewari, A., Gupta, N., Chaubey, S. K., Chaudhary, S., Ansari, S., et al. (2024) · Indian Journal of Endocrinology and Metabolism · doi:10.4103/ijem.ijem_42_23
Prevention and management of chronic kidney disease in diabetes
Barlovič, D. P., & Groop, P. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-88426-6.00004-x
Les nouveaux diabétiques observés à l’Hôpital Joseph Raseta Befelatanana d’Antananarivo (2002-2003)
Raherison, R. E., Ramilitiana, B., Raharinavalona, S. A., & Rakotomalala, D. (2015) · La revue médicale de Madagascar. · doi:10.62606/rmmao00141
Metadata
- Authors
- Moen, M. F., Zhan, M., Hsu, V. D., Walker, L. D., Einhorn, L. M., Seliger, S. L., & Fink, J. C.
- Affiliations
- University of Maryland, Baltimore (US)
- Corresponding author
- Fink, Jeffrey C.
- Venue
- Clinical Journal of the American Society of Nephrology
- Published
- 2009-06
- Volume
- 4
- Issue
- 6
- Pages
- 1121-1127
- ISSN
- 1555-9041 (ISSN-L)
- PMC
- PMC2689888
- OpenAlex
- W2146702281
- Semantic Scholar
- 6dd714ce42c6670e1867d104de400f22b50a7e1c
- Cited by
- 423
- References
- 18
- Citations by year
- 2026: 14 · 2025: 18 · 2024: 21 · 2023: 22 · 2022: 28 · 2021: 32 · 2020: 47 · 2019: 31 · 2018: 37 · 2017: 26 · 2016: 27 · 2015: 36 · 2014: 26 · 2013: 23 · 2012: 19
- FWCI
- 8.50
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Clinical Journal of the American Society of Nephrology (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R21DK075675)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Nephrology › Chronic Kidney Disease and Diabetes
- Health Sciences › Medicine › Nephrology › Dialysis and Renal Disease Management
- Keywords
- hypoglycemia, chronic kidney disease, diabetes mellitus, mortality, incidence, estimated glomerular filtration rate, veterans, patient safety, glucose monitoring
- MeSH terms
- Aged, Blood Glucose, Diabetic Nephropathies, Female, Glomerular Filtration Rate, Humans, Hypoglycemia, Male, Middle Aged, Retrospective Studies, Risk Factors, Comorbidity, Incidence, Renal Insufficiency, Chronic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.